Fri, September 23, 2022

Patrick Trucchio Maintained (BNTC) at Strong Buy with Decreased Target to $68 on, Sep 23rd, 2022

Patrick Trucchio of HC Wainwright & Co., Maintained "Benitec Biopharma Inc." (BNTC) at Strong Buy with Decreased Target from $170 to $68 on, Sep 23rd, 2022.

Patrick, nor any peers, have made any analyst calls on BNTC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30